Please assess the completion status of the following clinical trial:

Trial Title: Fecal Microbiota Transplant for Relapsing Clostridium Difficile Infection in Adults and Children Using a Frozen Encapsulated Inoculum

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria~* Patients with refractory, recurrent or relapsing C. difficile infection (CDI) defined as EITHER:~  * At least three episodes of mild-to-moderate CDI~ * At least two episodes of severe CDI resulting in hospitalization and associated with significant morbidity~ * One protracted episode of CDI, defined as at least 3 weeks of ongoing Grade 3 severe symptoms of CDI despite standard antimicrobial therapy for CDI~ * We expect that most, but not all, subjects will have tried and failed a taper of vancomycin.~* Willingness to accept risk of unrelated donor stool~* Age 7 and above. Seven is chosen as a lower limit based upon the legal age of assent. Based on the literature, most children aged 7 and above can be taught to swallow even large capsules through simple coaching techniques~* Able to consent for self, or parental assent/child assent as age appropriate~Exclusion criteria~* Delayed gastric emptying syndrome~* Known chronic aspiration~* Swallowing dysfunction or oral-motor dyscoordination.~* Inability or unwillingness to swallow multiple large capsules~* Pregnant women~* Patients with an acute illness unrelated to CDI or an acute exacerbation of underlying comorbid condition~* Patients with comorbidities associated with increased risk of serious infection following bacterial translocation, including but not limited to:~  * subjects on major immunosuppressive agents including high dose corticosteroids, calcineurin inhibitors, mTOR inhibitors, lymphocyte depleting biologic agents, anti-TNF agents, and others; chemotherapeutic anti-neoplastic agents\*~ * Patients with decompensated liver cirrhosis, advanced HIV/AIDS, recent bone marrow transplant, hypoglobulinemia or other cause of severe immunodeficiency\*~* Patients with a history of significant allergy to foods not excluded from the donor diet

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Capsule (Type: EXPERIMENTAL): Fecal microbiota transplant (stool transplant) from healthy, unrelated donor via frozen capsule

Based on this trial design, predict the completion outcome and termination type (if applicable).